Caricamento...
Risk of hypertension in cancer patients treated with abiraterone: a meta-analysis
BACKGROUND: Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We performed a systematic review and meta-analysis of randomized clinical trials to deter...
Salvato in:
| Pubblicato in: | Clin Hypertens |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6545007/ https://ncbi.nlm.nih.gov/pubmed/31168403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40885-019-0116-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|